Project description:We aim to the investigate the role of tamoxifen in breast cancer progression. LCC2 and MCF-7 cells were used as the resistant and sensitive model.

2018-12-26 | GSE118774 | GEO

Genome wide expression change in LCC2 and MCF-7 cells

Project description:Genome wide expression change in LCC2 and MCF-7 cells

| PRJNA486779 | ENA

ESRP1 knockdown in breast cancer cells

Project description:ESRP1 was knocked down in endocrine resistant LCC2 and LCC9 cells

2019-01-19 | GSE125355 | GEO

circRNA expression data from MCF-7, LCC2 and LCC9 cells

Project description:Acquired resistance to tamoxifen and fulvestrant is a challenging clinical problem in the treatment of hormone receptor-positive breast cancer patients. Non-coding RNAs (ncRNAs) could contribute to endocrine resistance but their specific roles in tamoxifen and fulvestrant resistance are not fully understood.

2020-11-18 | GSE159980 | GEO

lncRNA, mRNA, miRNA and circRNA expression data from MCF-7, LCC2 and LCC9 cells

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-11-18 | GSE159981 | GEO

Human circRNA expression profiling in plasma sample of hepatocellular carcinoma

Project description:Arraystar Human circRNA Microarray is designed for the global profiling of human circRNAs. In this study, we applied a circRNA microarray to screen the potential biomarker for HCC. 20 samples extracted from plasma samples including HCC group before operation, and after operation, CH group and control group. Each group contained five samples.

2021-03-02 | E-MTAB-8799 | biostudies-arrayexpress

RNA-Seq of human breast cancer cells MCF7 and LCC2 treated with Tamoxifen; EPZ or DMSO

Project description:RNA-Seq of human breast cancer cells MCF7 and LCC2 treated with Tamoxifen; EPZ or DMSO

2019-10-11 | E-MTAB-6892 | biostudies-arrayexpress